MIB1/Ki-67 labelling index can classify grade 2 breast cancer into two clinically distinct subgroups

Breast Cancer Research and Treatment
Mohammed A AleskandaranyAndrew R Green

Abstract

Histological grade is recognized as one of the strongest prognostic factors in operable breast cancer (BC). Although grade 1 and grade 3 tumours are biologically and clinically distinct, grade 2 tumours bear considerable difficulty in outcome prediction and planning therapies. Several attempts such as genomic grade index have been performed to subclassify grade 2 into two subgroups with clinical relevance. Here, we present evidence that the routinely evaluable immunohistochemical MIB1/Ki67 labelling index (MIB-LI) can classify grade 2 tumours into two clinically distinct subgroups. In this study, growth fractions of 1,550 primary operable invasive breast carcinomas were immunohistochemically assayed on full-face tissue sections using the MIB1 clone of Ki-67. Growth fractions were assessed as number of MIB1 positive nuclei in 1,000 tumour nuclei at high-power magnification and expressed as MIB1-LI. Using a 10% cut-point of MIB1-LI, grade 2 BCs were classified into low (49.8%) and high (50.2%) proliferative subgroups. Univariate and multivariate survival analysis revealed statistically significant differences between these subgroups regarding patients' BC specific survival (P < 0.001), and metastasis free survival (P < 0.001) whi...Continue Reading

References

Mar 1, 1990·Journal of Clinical Pathology·P A Hall, D A Levison
Oct 26, 1999·Critical Reviews in Oncology/hematology·C W ElstonS E Pinder
Feb 22, 2002·The Journal of Pathology·J LynchC E Gillett
Dec 6, 2002·The American Journal of Pathology·Mythily SrinivasanScott Jewell
Nov 10, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Robert L CampDavid L Rimm
Jan 11, 2005·The Journal of Pathology·Peter T SimpsonSunil R Lakhani
May 28, 2005·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·John S MeyerUNKNOWN Cooperative Breast Cancer Tissue Resource
Sep 1, 2005·Nature Clinical Practice. Oncology·Lisa M McShaneUNKNOWN Statistics Subcommittee of the NCI-EORTC Working Group on Cancer Diagnostics
Sep 2, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jan P A BaakEmiel A M Janssen
Feb 16, 2006·Journal of the National Cancer Institute·Christos SotiriouMauro Delorenzi
Feb 24, 2006·Nature Reviews. Cancer·Michael L WhitfieldCharles M Perou
Nov 10, 2006·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·L Pusztai, G N Hortobagyi
Mar 23, 2007·Breast Cancer Research and Treatment·Isabelle SoerjomataramJan Willem W Coebergh
May 3, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Xiao-Jun MaDennis Sgroi
Jun 12, 2008·Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology·M Ignatiadis, C Sotiriou
Aug 23, 2008·BMC Genomics·Benjamin Haibe-KainsChristos Sotiriou
Mar 26, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Emad A RakhaIan O Ellis
May 14, 2009·Journal of the National Cancer Institute·Maggie C U CheangTorsten O Nielsen
May 30, 2009·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Hervé BonnefoiDavid Cameron
Aug 28, 2009·International Journal of Cancer. Journal International Du Cancer·Mohammed A AleskandaranyIan O Ellis

❮ Previous
Next ❯

Citations

Nov 3, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·F BertucciF Penault-Llorca
Feb 26, 2013·Journal of Clinical Pathology·Nirmala Pathmanathan, Rosemary L Balleine
Sep 27, 2012·BMC Clinical Pathology·Shant Kishen Kanapathy PillaiChee-Onn Leong
Mar 4, 2014·Breast Cancer Research and Treatment·Alaa T AlshareedaEmad A Rakha
Nov 9, 2012·Breast Cancer Research and Treatment·Karin Milde-LangoschRalph M Wirtz
Apr 3, 2012·Breast Cancer : the Journal of the Japanese Breast Cancer Society·Satoshi HayashiSatoshi Hirata
Mar 20, 2012·Diagnostic Pathology·Arvydas LaurinaviciusJuozas Lazutka
Jun 19, 2012·The Breast : Official Journal of the European Society of Mastology·Concetta De CiccoGiovanni Paganelli
Jan 10, 2014·Journal of Clinical Pathology·Nirmala PathmanathanJohn Boyages
May 13, 2015·Future Oncology·Simon J Johnston, Kwok-Leung Cheung
Nov 30, 2011·Annales de pathologie·Anne Vincent-Salomon
Mar 13, 2014·The Breast : Official Journal of the European Society of Mastology·Gábor CserniClive Wells
Jul 7, 2016·Breast Cancer Research and Treatment·M A AleskandaranyE A Rakha
Nov 18, 2015·Applied Immunohistochemistry & Molecular Morphology : AIMM·Rehab M SamakaMohammed A Aleskandarany
Nov 26, 2015·Analytical Cellular Pathology (Amsterdam)·Rehab M SamakaNanes S Holah
Jul 14, 2016·Journal of Clinical Pathology·Emad A RakhaUNKNOWN UK National Coordinating Committee for Breast Pathology (EQA Scheme Steering Committee)
Jan 14, 2017·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Einas M YousefLouis A Gaboury
Feb 13, 2018·Pathology International·Tomoko DaiMasayuki Noguchi
Oct 16, 2018·Applied Immunohistochemistry & Molecular Morphology : AIMM·Marwa M DawoudEnas A B Elkhouly
Apr 12, 2011·Journal of Surgical Oncology·Sally GreenbergHope S Rugo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Carcinoma, Ductal

Ductal carcinoma is a malignant neoplasm involving the ductal systems of any of a number of organs, such as the mammary glands, pancreas, prostate or lacrimal gland. Discover the latest research on ductal carcinoma here.

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.